Michael Ardeljan

A list of Michael’s representative matters include:

General and Complex Commercial Matters

• Originated and led successful representation of a DeFi trading software corporation in connection with commercial dispute and impending litigation against a third-party business partner. Reached settlement on highly favorable terms*
• Represented a private equity fund in representations and warranties insurance coverage dispute with a third-party insurer, stemming from the acquisition of portfolio companies*
• Represented a private equity fund and its portfolio company in a commercial dispute with a third-party seller, relating to post-closing assistance and noncompete covenants*
• Successfully represented a leading pharmaceutical company to secure dismissal with prejudice and a rare award of attorneys’ fees in connection with vacatur petition filed in the Delaware Court of Chancery, concerning an alleged breach of contract related to the development of an ophthalmic drug*
• Represented a private equity fund in an international arbitration concerning an alleged breach of contract and business torts related to a portfolio company divestiture. Reached settlement on favorable terms*
• Represented a life sciences technology company in multiple arbitrations concerning alleged breaches of contract related to joint research development for a healthcare technology. Reached global settlement on favorable terms*
• Represented a high-net-worth individual in a commercial dispute with third-party contractors*
• Represented an asset manager in connection with risk assessments for investment decisions*
• Represented a public utility company in a breach of contract litigation filed in federal court in the Southern District of New York, concerning state-backed expropriation of ownership stake in the company*

Business Restructuring and Bankruptcy Matters

• Represented a public telecommunications corporation and its subsidiaries and affiliates in connection with a debt financing strategy and anticipated litigation related to impending restructuring*
• Represented an ad hoc group of lenders in litigation before the United States Bankruptcy Court for the Southern District of Texas, in connection with chapter 11 restructuring plan disputes among different stakeholders. Successfully quashed all discovery sought against ad hoc group*

Corporate Governance and Shareholder Matters

• Represented a high-net-worth individual in corporate governance, commercial, and white-collar engagement related to an investor dispute. Reached settlement on favorable terms*
• Represented the officers and directors of a private equity fund portfolio company in the Delaware Court of Chancery concerning alleged breaches of fiduciary duty. Reached settlement on favorable terms*
• Represented a private equity fund in connection with portfolio company corporate governance dispute*
• Represented an international telecommunications company in derivative stockholder litigation filed in the Delaware Court of Chancery, stemming from merger with a competitor*

Business and Mass Toxic Tort Matters

• Represented a private equity fund portfolio company in connection with a congressional inquiry and mass toxic tort class action litigation related to public utility failures*
• Represented a major financial institution in litigation filed in the Southern District of New York, concerning alleged business torts arising from client relationships*
• Represented a public utility company in mass tort litigation and regulatory investigations stemming from natural disasters that resulted in global settlement*

Antitrust Matters

• Represented a premier healthcare system in antitrust litigation in federal court, concerning alleged violations of the Sherman Act and state antitrust law related to contracting with healthcare payors*
• Represented a private equity fund portfolio company in connection with European antitrust litigation*
• Represented a cellular technology company in several simultaneous high-stakes antitrust and breach of contract actions filed by regulators, public companies, and putative consumer classes in US federal court and various fora worldwide that resulted in global settlements and/or successful appeals*
• Represented a financial institution in antitrust litigation filed in federal court in the Southern District of New York, alleging Sherman Act violations related to securities bid pricing*

Intellectual Property Matters

• Represented a medical device manufacturer in connection with intellectual property licensing dispute related to novel European medical device regulations*
• Represented a private home security technology company to prosecute patent infringement litigation against a competitor*

Regulatory and Enforcement Matters

• Represented a medical device manufacturer in connection with regulatory healthcare litigation*
• Represented a life sciences technology companies in a civil investigative inquiries before the Financial Industry Regulatory Authority (FINRA)*
• Represented a private equity fund portfolio company in Germany in connection with regulatory compliance and anti-corruption, anti-bribery, and anti-money laundering systems*
• Represented a public company in government enforcement matters. Entered into a deferred prosecution agreement on favorable terms*

Pro Bono Matters

• Represented a New York State municipality and its supervisor in pro bono constitutional litigation concerning alleged First Amendment and state law violations related to the municipality’s display of a foreign flag in solidarity with victims of a terrorist attack*
• Represented a putative class of state prisoners in pro bono constitutional litigation filed in federal court in the Southern District of New York, concerning alleged Eighth Amendment violations related to juvenile offender parole release eligibility*
• Represented a disabled individual in pro bono litigation before the Social Security Administration, successfully obtaining retroactive and indefinite prospective disability benefits on appeal*

*Matter handled prior to joining Latham